[#item_full_content]
Lilly Gets FDA Approval for Eczema Drug Ebglyss – Eli Lilly (NYSE:LLY), Biogen (NASDAQ:BIIB)
2024-09-17T19:08:04-04:00September 17th, 2024|
Related Posts
-
BOJ Meeting to Test Fate of Yen-Sensitive Japanese Stocks
September 19th, 2024